KCL-286
KCL-286 is a potent and orally bioavailable retinoic acid receptor beta (RARβ) agonist designed for research into spinal cord injury (SCI) treatment. It is used in both in vitro and in vivo studies to investigate neuroprotection and axonal regeneration following neural trauma.
Product Specifications
CAS Number
1952276-71-9
Product Name Alternative
Retinoid Receptor, RetinoidReceptor
Field of Research
Metabolism Research
Purity
99.88% (May vary between batches)
Smiles
O=C (O) C=1C=CC (=CC1) C2=NOC (=N2) C=3OC=4C (C3) =C (C=CC4C) C
Molecular Formula
C19H14N2O4
Molecular Weight
334.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
